Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment.
about
High-throughput sequencing for noninvasive disease detection in hematologic malignancies.Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma.Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.
P2860
Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Minimal residual disease in ma ...... ology and impact on treatment.
@ast
Minimal residual disease in ma ...... ology and impact on treatment.
@en
type
label
Minimal residual disease in ma ...... ology and impact on treatment.
@ast
Minimal residual disease in ma ...... ology and impact on treatment.
@en
prefLabel
Minimal residual disease in ma ...... ology and impact on treatment.
@ast
Minimal residual disease in ma ...... ology and impact on treatment.
@en
P1476
Minimal residual disease in ma ...... iology and impact on treatment
@en
P2093
Christiane Pott
P304
P356
10.1182/ASHEDUCATION-2016.1.437
P50
P577
2016-12-01T00:00:00Z